CRYOPORT, INC. (NASDAQ:CYRX) Files An 8-K Results of Operations and Financial Condition

0
CRYOPORT, INC. (NASDAQ:CYRX) Files An 8-K Results of Operations and Financial Condition

CRYOPORT, INC. (NASDAQ:CYRX) Files An 8-K Results of Operations and Financial Condition
Item 2.02.

Results of Operations and Financial Condition.

On March 7, 2019, Cryoport, Inc. (the “Registrant”) issued a press release announcing its financial results for the fourth quarter and fiscal year ended December 31, 2018. A copy of the press release issued by the Registrant on March 7, 2019 is attached as Exhibit 99.1.

The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits. The following material is filed as an exhibit to this Current Report on Form 8-K:

Cryoport, Inc. Exhibit
EX-99.1 2 tv515783_ex99-1.htm EXHIBIT 99.1   Exhibit 99.1       Cryoport Reports 64% Growth for Fiscal Year 2018 – – – Cryoport now supports 357 clinical trials in the Americas and EMEA with 47 in Phase III   IRVINE,…
To view the full exhibit click here

About CRYOPORT, INC. (NASDAQ:CYRX)

Cryoport, Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company’s Cryoport Express Solution includes a cloud-based logistics operating platform, which is branded as the Cryoportal. The Company’s Cryoport Express Solutions are made up of the Cryoportal software platform, Cryoport Express Shippers, Cryoport Express Smart Pak data loggers and its life sciences cold chain logistics expertise. The Cryoportal is used by the Company, its clients and its business partners to automate the entry of orders, prepare customs documentation, and to facilitate status and location monitoring of shipped orders while in transit.